<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>microvascular complications &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/microvascular-complications/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 08 Oct 2026 02:26:27 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>microvascular complications &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Semaglutide Shifts Inflammation Blood Markers in Diabetes, With a Twist for Eye Disease</title>
		<link>https://bioengineer.org/semaglutide-shifts-inflammation-blood-markers-in-diabetes-with-a-twist-for-eye-disease/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Thu, 08 Oct 2026 02:26:27 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[C-reactive protein]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[GLP-1 receptor agonist]]></category>
		<category><![CDATA[Inflammatory Biomarkers]]></category>
		<category><![CDATA[lipid profile]]></category>
		<category><![CDATA[microvascular complications]]></category>
		<category><![CDATA[Neutrophil-to-lymphocyte ratio]]></category>
		<category><![CDATA[retrospective cohort study]]></category>
		<category><![CDATA[semaglutide]]></category>
		<category><![CDATA[Systemic inflammation]]></category>
		<category><![CDATA[Type 2 diabetes]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=406677</guid>

					<description><![CDATA[A retrospective study of 99 patients in Saudi Arabia found that semaglutide significantly altered systemic inflammation index ratios in type 2 diabetes, with the correlation between C-reactive protein and a composite neutrophil-lymphocyte-platelet ratio flipping direction depending on whether patients had diabetic retinopathy.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">406677</post-id>	</item>
	</channel>
</rss>
